Pravastatin vs Tofacitinib
Pravastatin vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Pravastatin and Tofacitinib.
Mechanism of Action
Pravastatin: Competitive inhibitor of HMG-CoA reductase.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Pravastatin β 1.8 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Pravastatin β C23H36O7; Tofacitinib β C16H20N6O.
Molecular Weight: Pravastatin β 424.5280 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Pravastatin β Small molecule; Tofacitinib β Small molecule.